Cellular mechanism underlying the facilitation of contractile response induced by IL-25 in mouse tracheal smooth muscle. 2022

Ze-Xin Huang, and Zhuo-Er Qiu, and Lei Chen, and Xiao-Chun Hou, and Yun-Xin Zhu, and Wen-Liang Zhou, and Yi-Lin Zhang
School of Life Sciences, Sun Yat-sen University, Guangzhou, People's Republic of China.

Asthma is a common heterogeneous respiratory disease characterized by airway inflammation and airway hyperresponsiveness (AHR) which is associated with abnormality in smooth muscle contractility. The epithelial cell-derived cytokine IL-25 is implicated in type 2 immune pathology including asthma, whereas the underlying mechanisms have not been fully elucidated. This study aims to investigate the effects of IL-25 on mouse tracheal smooth muscle contractility and elucidate the cellular mechanisms. Incubation with IL-25 augmented the contraction of mouse tracheal smooth muscles, which could be suppressed by the L-type voltage-dependent Ca2+ channel (L-VDCC) blocker nifedipine. Furthermore, IL-25 enhanced the cytosolic Ca2+ signals and triggered the upregulation of α1C L-VDCC (CaV1.2) in primary cultured mouse tracheal smooth muscle cells. Knocking down IL-17RA/IL-17RB receptors or inhibiting the transforming growth factor-β-activated kinase 1 (TAK1)-tumor progression locus 2 (TPL2)-MAPK kinase 1/2 (MEK1/2)-ERK1/2-activating protein-1 (AP-1) signaling pathways suppressed the IL-25-elicited upregulation of CaV1.2 and hyperreactivity in tracheal smooth muscles. Moreover, inhibition of TPL2, ERK1/2 or L-VDCC alleviated the AHR symptom induced by IL-25 in a murine model. This study revealed that IL-25 potentiated the contraction of tracheal smooth muscle and evoked AHR via activation of TPL2-ERK1/2-CaV1.2 signaling, providing novel targets for the treatment of asthma with a high-IL-25 phenotype.

UI MeSH Term Description Entries
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D014132 Trachea The cartilaginous and membranous tube descending from the larynx and branching into the right and left main bronchi. Tracheas
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D020381 Interleukin-17 A proinflammatory cytokine produced primarily by T-LYMPHOCYTES or their precursors. Several subtypes of interleukin-17 have been identified, each of which is a product of a unique gene. IL-17,CTLA-8,CTLA8,Cytokine CX2,Cytokine ML-1,Cytotoxic T lymphocyte-Associated Antigen 8,IL-17A,IL-17B,IL-17C,IL-17E,IL-17F,Interleukin 17,Interleukin-17A,Interleukin-17B,Interleukin-17C,Interleukin-17E,Interleukin-17F,Interleukin-25,CX2, Cytokine,Cytokine ML 1,Cytotoxic T lymphocyte Associated Antigen 8,IL 17E,Interleukin 17A,Interleukin 17B,Interleukin 17C,Interleukin 17E,Interleukin 17F,Interleukin 25
D020746 Calcium Channels, L-Type Long-lasting voltage-gated CALCIUM CHANNELS found in both excitable and non-excitable tissue. They are responsible for normal myocardial and vascular smooth muscle contractility. Five subunits (alpha-1, alpha-2, beta, gamma, and delta) make up the L-type channel. The alpha-1 subunit is the binding site for calcium-based antagonists. Dihydropyridine-based calcium antagonists are used as markers for these binding sites. Dihydropyridine Receptors,L-Type Calcium Channels,L-Type VDCC alpha-1 Subunit,L-Type Voltage-Dependent Calcium Channel,Long-Lasting Calcium Channel,Long-Lasting Calcium Channels,Receptors, Dihydropyridine,Dihydropyridine Receptor,L-Type Calcium Channel,L-Type VDCC,L-Type VDCC alpha-2 Subunit,L-Type VDCC beta Subunit,L-Type VDCC delta Subunit,L-Type VDCC gamma Subunit,L-Type Voltage-Dependent Calcium Channels,Calcium Channel, L-Type,Calcium Channel, Long-Lasting,Calcium Channels, L Type,Calcium Channels, Long-Lasting,Channel, Long-Lasting Calcium,L Type Calcium Channel,L Type Calcium Channels,L Type VDCC,L Type VDCC alpha 1 Subunit,L Type VDCC alpha 2 Subunit,L Type VDCC beta Subunit,L Type VDCC delta Subunit,L Type VDCC gamma Subunit,L Type Voltage Dependent Calcium Channel,L Type Voltage Dependent Calcium Channels,Long Lasting Calcium Channel,Long Lasting Calcium Channels,Receptor, Dihydropyridine,VDCC, L-Type

Related Publications

Ze-Xin Huang, and Zhuo-Er Qiu, and Lei Chen, and Xiao-Chun Hou, and Yun-Xin Zhu, and Wen-Liang Zhou, and Yi-Lin Zhang
July 2012, Molecular and cellular biochemistry,
Ze-Xin Huang, and Zhuo-Er Qiu, and Lei Chen, and Xiao-Chun Hou, and Yun-Xin Zhu, and Wen-Liang Zhou, and Yi-Lin Zhang
October 2014, European journal of pharmacology,
Ze-Xin Huang, and Zhuo-Er Qiu, and Lei Chen, and Xiao-Chun Hou, and Yun-Xin Zhu, and Wen-Liang Zhou, and Yi-Lin Zhang
February 2007, European journal of pharmacology,
Ze-Xin Huang, and Zhuo-Er Qiu, and Lei Chen, and Xiao-Chun Hou, and Yun-Xin Zhu, and Wen-Liang Zhou, and Yi-Lin Zhang
June 2009, Pediatric pulmonology,
Ze-Xin Huang, and Zhuo-Er Qiu, and Lei Chen, and Xiao-Chun Hou, and Yun-Xin Zhu, and Wen-Liang Zhou, and Yi-Lin Zhang
February 1987, Canadian journal of physiology and pharmacology,
Ze-Xin Huang, and Zhuo-Er Qiu, and Lei Chen, and Xiao-Chun Hou, and Yun-Xin Zhu, and Wen-Liang Zhou, and Yi-Lin Zhang
October 1977, The Journal of pharmacology and experimental therapeutics,
Ze-Xin Huang, and Zhuo-Er Qiu, and Lei Chen, and Xiao-Chun Hou, and Yun-Xin Zhu, and Wen-Liang Zhou, and Yi-Lin Zhang
July 1978, The Journal of physiology,
Ze-Xin Huang, and Zhuo-Er Qiu, and Lei Chen, and Xiao-Chun Hou, and Yun-Xin Zhu, and Wen-Liang Zhou, and Yi-Lin Zhang
January 1992, Archives of toxicology,
Ze-Xin Huang, and Zhuo-Er Qiu, and Lei Chen, and Xiao-Chun Hou, and Yun-Xin Zhu, and Wen-Liang Zhou, and Yi-Lin Zhang
November 1997, The American journal of physiology,
Ze-Xin Huang, and Zhuo-Er Qiu, and Lei Chen, and Xiao-Chun Hou, and Yun-Xin Zhu, and Wen-Liang Zhou, and Yi-Lin Zhang
August 1987, Journal of applied physiology (Bethesda, Md. : 1985),
Copied contents to your clipboard!